IBRNiShares Neuroscience and Healthcare ETF
Grow my money#2278 of 2944 for Grow my money
Seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from neuroscience.
iShares · Since 2022 (3 years)
Annual Cost
0.47%
#2134 out of 5,332 ETFs
Fund Size
$5M
#4833 out of 5,332 ETFs
Dividend Yield
0.97%
Track Record
3 years
#2848 out of 5,332 ETFs
Performance
1 Year
+53.3%
3 Years
+12.7%
5 Years
N/A
What's inside
Asset class
Focus
Medical Devices
Asset allocation
Stocks
100.0%
Cash
0.0%
Sector breakdown
Healthcare
100.0%
Top holdings
Xenon Pharmaceuticals IncXENE5.2%
Alkermes PLCALKS4.6%
Centessa Pharmaceuticals PLC ADRCNTA4.2%
Scholar Rock Holding CorpSRRK4.1%
PTC Therapeutics IncPTCT4.1%
Arrowhead Pharmaceuticals IncARWR4.0%
Axsome Therapeutics IncAXSM3.9%
Praxis Precision Medicines Inc Ordinary SharesPRAX3.9%
Neurocrine Biosciences IncNBIX3.9%
argenx SE ADRARGX3.8%
Risk profile
Volatility (1Y)
25.9%
High
Max drawdown
-35.4%
Worst peak-to-trough loss
Sharpe (3Y)
0.47
Below average
Sortino (3Y)
0.68
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05